Investigation of retinal morphology alterations using spectral domain optical coherence tomography in a mouse model of retinal branch and central retinal vein occlusion

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Ebneter, Andreas ^a   Agca, Cavit ^a   Dysli, Chantal ^a   Zinkernagel, Martin S ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CELL DENSITY; CENTRAL RETINA VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; CONTROLLED STUDY; EYE FUNDUS; HISTOPATHOLOGY; HYPOXIA; INFRARED PHOTOGRAPHY; LASER COAGULATION; MALE; MOUSE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PHENOTYPE; RETINA CONE; RETINA EDEMA; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; RETINAL THICKNESS; SLIT LAMP; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VENOUS STASIS; ANIMAL; DISEASE MODEL; FLUORESCENCE ANGIOGRAPHY; PATHOLOGY; PROCEDURES; RETINA; RETINA ARTERY OCCLUSION; RETINA VEIN OCCLUSION;

ANIMALIA; MAMMALIA; RATTUS; RODENTIA;

ANIMALS; DISEASE MODELS, ANIMAL; FLUORESCEIN ANGIOGRAPHY; LASER COAGULATION; MALE; MICE; RETINA; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84924975504     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119046     Document Type: Article

References (44)

1. Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, et al. The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010; 117: 313-319. doi: 10.1016/j.ophtha.2009.07.017 PMID: 20022117
2. McAllister IL. Central retinal vein occlusion: a review. Clin Experiment Ophthalmol. 2012; 40: 48-58. doi: 10.1111/j.1442-9071.2011.02713.x PMID: 22003973
3. Jaulim A, Ahmed B, Khanam T, Chatziralli IP. Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Retina. 2013; 33: 901-910. doi: 10.1097/IAE.0b013e3182870c15 PMID: 23609064
4. Bek T. Inner retinal ischaemia: current understanding and needs for further investigations. Acta Ophthalmol. 2009; 87: 362-367. doi: 10.1111/j.1755-3768.2008.01429.x PMID: 19416114
5. O'Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol. 2008; 126: 692-699. doi: 10.1001/archopht.126.5.692 PMID: 18474782
6. Campochiaro PA. Anti-vascular endothelial growth factor treatment for retinal vein occlusions. Ophthalmologica. 2012; 227 Suppl 1: 30-35. doi: 10.1159/000337157 PMID: 22517123
7. Wolf S, Arend O, Bertram B, Remky A, Schulte K, Wald KJ, et al. Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study. Graefes Arch Clin Exp Ophthalmol. 1994; 232: 33-39. PMID: 8119599
8. McAllister IL, Gillies ME, Smithies LA, Rochtchina E, Harper CA, Daniell MD, et al. The Central Retinal Vein Bypass Study: A Trial of Laser-induced Chorioretinal Venous Anastomosis for Central Retinal Vein Occlusion. Ophthalmology. 2010; 117: 954-965. doi: 10.1016/j.ophtha.2009.10.026 PMID: 20163872
9. Ehlers JP, Fekrat S. Retinal vein occlusion: beyond the acute event. Surv Ophthalmol. 2011; 56: 281-299. doi: 10.1016/j.survophthal.2010.11.006 PMID: 21601903
10. Weinberg DV, Wahle AE, Ip MS, Scott IU, VanVeldhuisen PC, Boldi BA. Score Study Report 12: Development of venous collaterals in the Score Study. Retina. 2013; 33: 287-295. doi: 10.1097/IAE. 0b013e318263d106 PMID: 22972448
11. Feng J, Zhao T, Zhang Y, Ma Y, Jiang Y. Differences in aqueous concentrations of cytokines in macular edema secondary to branch and central retinal vein occlusion. PLoS One. 2013; 8: e68149. doi: 10. 1371/journal.pone.0068149 PMID: 23861862
12. Maier R, Steinbrugger I, Haas A, Selimovic M, RennerW, El-Shabrawi Y, et al. Role of inflammation-related gene polymorphisms in patients with central retinal vein occlusion. Ophthalmology. 2011; 118: 1125-1129. doi: 10.1016/j.ophtha.2010.10.014 PMID: 21269700
13. Noma H, Mimura T, Eguchi S. Association of inflammatory factors with macular edema in branch retinal vein occlusion. JAMA Ophthalmol. 2013; 131: 160-165. doi: 10.1001/2013.jamaophthalmol.228 PMID: 23411880
14. Comyn O, Lightman SL, Hykin PG. Corticosteroid intravitreal implants vs. ranibizumab for the treatment of vitreoretinal disease. Curr Opin Ophthalmol. 2013; 24: 248-254. doi: 10.1097/ICU. 0b013e32835fab27 PMID: 23518614
15. Hayreh SS. Occlusion of the central retinal vessels. Br J Ophthalmol. 1965; 49: 626-645. PMID: 4954984
16. McAllister IL, Vijayasekaran S, Yu DY. Intravitreal tenecteplase (metalyse) for acute management of retinal vein occlusions. Invest Ophthalmol Vis Sci. 2013; 54: 4910-4918. doi: 10.1167/iovs.13-11967 PMID: 23766477
17. Mendrinos E, Petropoulos IK, Mangioris G, Tsilimbaris MK, Papadopoulou DN, Geka A, et al. Vasomotor effect of intravitreal juxta-arteriolar injection of L-lactate on the retinal arterioles after acute branch retinal vein occlusion in minipigs. Invest Ophthalmol Vis Sci. 2011; 52: 3215-3220. doi: 10.1167/iovs. 10-6888 PMID: 21345988
18. Shen LJ, Chen YQ, Wei LL, Wu W, Wang ZY, Liu Y, et al. Bypassing occluded retinal main vessel segments in isolated arterially perfused caprine eyes. Curr Eye Res. 2009; 34: 415-420. PMID: 19899975
19. Campbell FP. Retinal vein occlusion; an experimental study. Arch Ophthalmol. 1961; 65: 2-10. PMID: 13690232
20. Tameesh MK, Lakhanpal RR, Fujii GY, Javaheri M, Shelley TH, D'Anna S, et al. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs. Am J Ophthalmol. 2004; 138: 829-839. PMID: 15531319
21. Ameri H, Ratanapakorn T, Rao NA, Chader GJ, Humayun MS. Natural course of experimental retinal vein occlusion in rabbit; arterial occlusion following venous photothrombosis. Graefes Arch Clin Exp Ophthalmol. 2008; 246: 1429-1439. doi: 10.1007/s00417-008-0878-4 PMID: 18642023
22. Chuang LH, Wu WC, Yeung L, Wang NK, Hwang YS, Chen KJ, et al. Serum concentration of bevacizumab after intravitreal injection in experimental branch retinal vein occlusion. Ophthalmic Res. 2011; 45: 31-35. doi: 10.1159/000315617 PMID: 20714188
23. Rehak M, Drechsler F, Koferl P, Hollborn M, Wiedemann P, Bringmann A, et al. Effects of intravitreal triamcinolone acetonide on retinal gene expression in a rat model of central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2011; 249: 1175-1183. doi: 10.1007/s00417-011-1683-z PMID: 21487926
24. Zhang Y, Fortune B, Atchaneeyasakul LO, McFarland T, Mose K, Wallace P, et al. Natural history and histology in a rat model of laser-induced photothrombotic retinal vein occlusion. Curr Eye Res. 2008; 33: 365-376. doi: 10.1080/02713680801939318 PMID: 18398711
25. Grant MB, May WS, Caballero S, Brown GA, Guthrie SM, Mames RN, et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med. 2002; 8: 607-612. PMID: 12042812
26. Scheppke L, Aguilar E, Gariano RF, Jacobson R, Hood J, Doukas J, et al. Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. J Clin Invest. 2008; 118: 2337-2346. doi: 10.1172/JCI33361 PMID: 18483622
27. Zhang H, Sonoda KH, Qiao H, Oshima T, Hisatomi T, Ishibashi T. Development of a new mouse model of branch retinal vein occlusion and retinal neovascularization. Jpn J Ophthalmol. 2007; 51: 251-257. PMID: 17660984
28. Fischer MD, Huber G, Beck SC, Tanimoto N, Muehlfriedel R, Fahl E, et al. Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography. PLoS One. 2009; 4: e7507. doi: 10.1371/journal.pone.0007507 PMID: 19838301
29. Berger A, Cavallero S, Dominguez E, Barbe P, Simonutti M, Sahel JA, et al. Spectral-domain optical coherence tomography of the rodent eye: highlighting layers of the outer retina using signal averaging and comparison with histology. PLoS One. 2014; 9: e96494. doi: 10.1371/journal.pone.0096494 PMID: 24788712
30. Nakao S, Arita R, Nakama T, Yoshikawa H, Yoshida S, Enaida H, et al. Wide-field laser ophthalmoscopy for mice: a novel evaluation system for retinal/choroidal angiogenesis in mice. Invest Ophthalmol Vis Sci. 2013; 54: 5288-5293. doi: 10.1167/iovs.13-11946 PMID: 23860759
31. Fischer MD, Zhour A, Kernstock CJ. Phenotyping of mouse models with OCT. Methods Mol Biol. 2013; 935: 79-85. doi: 10.1007/978-1-62703-080-9-5 PMID: 23150361
32. Lozano DC, Twa MD. Development of a rat schematic eye from in vivo biometry and the correction of lateral magnification in SD-OCT imaging. Invest Ophthalmol Vis Sci. 2013; 54: 6446-6455. doi: 10. 1167/iovs.13-12575 PMID: 23989191
33. Chidlow G, Shibeeb O, Plunkett M, Casson RJ, Wood JP. Glial cell and inflammatory response to retinal laser treatment: comparison of a conventional photocoagulator and a novel, 3-nanosecond pulse laser. Invest Ophthalmol Vis Sci. 2006; 54: 2319-2332.
34. Paques M, Tadayoni R, Sercombe R, Laurent P, Genevois O, Gaudric A, et al. Structural and hemodynamic analysis of the mouse retinal microcirculation. Invest Ophthalmol Vis Sci. 2003; 44: 4960-4967. PMID: 14578423
35. Wilson CA, Hatchell DL. Photodynamic retinal vascular thrombosis. Rate and duration of vascular occlusion. Invest Ophthalmol Vis Sci. 1991; 32: 2357-2365. PMID: 2071346
36. Genevois O, Paques M, Simonutti M, Sercombe R, Seylaz J, Gaudric A, et al. Microvascular remodeling after occlusion-recanalization of a branch retinal vein in rats. Invest Ophthalmol Vis Sci. 2004; 45: 594-600. PMID: 14744903
37. Yoshimura T, Sonoda KH, Sugahara M, Mochizuki Y, Enaida H, Oshima Y, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One. 2009; 4: e8158. doi: 10. 1371/journal.pone.0008158 PMID: 19997642
38. Noma H, Funatsu H, Mimura T, Harino S, Hori S. Vitreous Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Macular Edema with Central Retinal Vein Occlusion. Ophthalmology. 2009; 116: 87-93. doi: 10.1016/j.ophtha.2008.09.034 PMID: 19118700
39. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005; 140: 256-261. PMID: 16086947
40. Karia N. Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol. 2010; 4: 809-816. PMID: 20689798
41. Bringmann A, Reichenbach A, Wiedemann P. Pathomechanisms of cystoid macular edema. Ophthalmic Res. 2004; 36: 241-249. PMID: 15583429
42. Park SP, Ahn JK, Mun GH. Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion. Retina. 2010; 30: 281-286. doi: 10.1097/IAE.0b013e3181b9f153 PMID: 19881397
43. Yanoff M, Fine BS, Brucker AJ, Eagle RC Jr. Pathology of human cystoid macular edema. Surv Ophthalmol. 1984; 28 Suppl: 505-511. PMID: 6463850
44. Scholl S, Kirchhof J, Augustin AJ. Pathophysiology of macular edema. Ophthalmologica. 2010; 224 Suppl 1: 8-15. doi: 10.1159/000315155 PMID: 20714176